Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026

Health Catalyst, Inc. (Nasdaq: HCAT), a prominent provider of data and analytics technology for healthcare organizations, is set to announce its operating results for the fourth quarter and year-end 2025. The announcement is scheduled for Thursday, March 12, 2026, following the market's closure. Interested parties can access the results during a conference call at 5:00 PM ET on the same day. U.S. participants can join by calling 800-343-5172, while international participants can dial 203-518-9856, using the conference ID “HCATQ425.” In addition to the call, a live audio webcast will be available on Health Catalyst's investor relations website, along with an on-demand replay that will remain accessible for approximately 90 days.

Health Catalyst specializes in providing innovative data and analytics solutions aimed at improving healthcare delivery. With over 1,100 global organizations relying on its comprehensive offerings, including the Health Catalyst Ignite™ cloud-based platform and AI-enabled analytics, the company plays a crucial role in enhancing clinical, financial, and operational efficiencies within healthcare systems. By transforming complex patient data into actionable insights, Health Catalyst helps organizations achieve measurable outcomes, positively impacting hundreds of millions of patient records.

The company's long-standing mission and proven history of generating billions in measurable results highlight its status as a catalyst for significant improvements and innovation within the healthcare sector. For further inquiries, interested parties can contact Kathryn Mykleseth, Director of Public Relations and Communications, or Matt Hopper, SVP of Finance and Head of Investor Relations, via the provided email addresses.

As Health Catalyst (Nasdaq: HCAT) approaches the announcement of its fourth quarter and year-end operating results for 2025 on March 12, 2026, investors should prepare for potential market volatility and strategic opportunities. The company, a provider of data and analytics solutions focused on improving healthcare outcomes, faces a critical inflection point in its growth trajectory.

Investors should pay close attention to key performance indicators such as revenue growth, customer acquisition rates, and gross margins. Given Health Catalyst's footprint with over 1,100 healthcare organizations, a strong customer retention rate will be essential in reviewing their quarterly performance. Analysts should evaluate whether these metrics align with or exceed market expectations, as such results could lead to significant stock price movement.

The conference call following the earnings release will provide crucial insights into management's outlook for future growth, including any new product launches or expansions in service offerings. Particularly noteworthy will be any discussions regarding the integration of AI-enabled analytics into existing solutions, as this could be a differentiating factor in maintaining competitive advantages in the healthcare sector.

Additionally, investors should consider external factors that might impact Health Catalyst’s operations, such as regulatory changes within healthcare data management and competition from emerging technologies. The broader economic conditions, including interest rates and healthcare spending trends, can also influence performance predictions.

To mitigate risks, diversifying portfolios and setting target prices based on anticipated earnings surprises could be prudent. If the earnings report reflects strong fundamentals, it could provide a buying opportunity; however, if results fall short, it may be wise to reevaluate positions in Health Catalyst.

In summary, closely monitoring the upcoming earnings report and the management's forward guidance will be essential for making informed investment decisions regarding Health Catalyst.